SHENZHEN, China, Aug. 8 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide today announced that it will report its financial results for the second quarter ended June 30, 2008, after the U.S. market closes on September 3, 2008. Mindray’s management will hold an earnings conference call at 8:00 a.m. on September 4, 2008 U.S. Eastern Time (8:00 p.m. on September 4, 2008 Beijing/Hong Kong Time) to discuss results with investors.
As announced in May 2008, Mindray changed its reporting currency to the U.S. Dollar (USD) from Chinese Renminbi effective April 1, 2008. Accordingly, Mindray will present historical financial results retranslated into USD in order to allow same currency comparisons to future financial results, to be released in USD. Mindray will release these historical financial results presented in USD on August 26, 2008. This retranslation does not reflect any change in the underlying historical results and reflects only exchange rate recalculation into USD based on the accounting guidance for retranslation into a new reporting currency.
Dial-in details for the earnings conference call are as follows:
Hong Kong: +852-3002-1672
U.S. Toll Free: +1-800-638-5439
International: +1-617-614-3945
Passcode for all regions: Mindray
A replay of the conference call may be accessed by phone at the following numbers until September 15, 2008.
U.S. Toll Free: +1-888-286-8010
International: +1-617-801-6888
Passcode: 42471484
Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray’s website at http://www.mindray.com .
About Mindray
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey. Mindray also has another 12 international sales and service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow, Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver.
For more information, please visit http://www.mindray.com .
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including statements about Mindray’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public filings with the Securities and Exchange Commission. All information provided in this press release is as of August 4, 2008, and Mindray undertakes no duty to update such information, except as required under applicable law.
For investor and media inquiries, please contact:
In the U.S:
Evan Smith,
FD
Tel: +1-212-850-5606
Email: evan.smith@fd.com
John Capodanno,
FD
Tel: +1-212-850-5705
Email: john.capodanno@fd.com
In China:
May Li
Mindray Medical International Limited
Tel: +86-755-2658-2518
Email: Susan.Du@Mindray.com
